Terms: = Lung cancer AND MAF, MGC71685, 4094, ENSG00000178573 AND Diagnosis
8 results:
1. Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.
Provencio M; Serna-Blasco R; Franco F; Calvo V; Royuela A; Auglytė M; Sánchez-Hernández A; de Julián Campayo M; García-Girón C; Dómine M; Blasco A; Sánchez JM; Oramas J; Bosch-Barrera J; Sala MÁ; Sereno M; Ortega AL; Chara L; Hernández B; Padilla A; Coves J; Blanco R; Balsalobre J; Mielgo X; Bueno C; Jantus-Lewintre E; Molina-Vila MÁ; Romero A
Eur J Cancer; 2021 May; 149():61-72. PubMed ID: 33831609
[TBL] [Abstract] [Full Text] [Related]
2. An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes.
Liu Z; Deng M; Wu L; Zhang S
Mol Med; 2020 May; 26(1):48. PubMed ID: 32434476
[TBL] [Abstract] [Full Text] [Related]
3. Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.
Jiang R; Zhang B; Teng X; Hu P; Xu S; Zheng Z; Liu R; Tang T; Ye F
Sci Rep; 2020 Feb; 10(1):2070. PubMed ID: 32034196
[TBL] [Abstract] [Full Text] [Related]
4. Impact of Rare and Common Genetic Variants on Diabetes diagnosis by Hemoglobin A1c in Multi-Ancestry Cohorts: The Trans-Omics for Precision Medicine Program.
Sarnowski C; Leong A; Raffield LM; Wu P; de Vries PS; DiCorpo D; Guo X; Xu H; Liu Y; Zheng X; Hu Y; Brody JA; Goodarzi MO; Hidalgo BA; Highland HM; Jain D; Liu CT; Naik RP; O'Connell JR; Perry JA; Porneala BC; Selvin E; Wessel J; Psaty BM; Curran JE; Peralta JM; Blangero J; Kooperberg C; Mathias R; Johnson AD; Reiner AP; Mitchell BD; Cupples LA; Vasan RS; Correa A; Morrison AC; Boerwinkle E; Rotter JI; Rich SS; Manning AK; Dupuis J; Meigs JB; ; ; ;
Am J Hum Genet; 2019 Oct; 105(4):706-718. PubMed ID: 31564435
[TBL] [Abstract] [Full Text] [Related]
5. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
[TBL] [Abstract] [Full Text] [Related]
6. Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions.
Li W; Qiu T; Ling Y; Gao S; Ying J
Mol Oncol; 2018 May; 12(5):677-689. PubMed ID: 29518290
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of an ultra-high sensitive next-generation sequencing assay for molecular diagnosis of clinical oncology.
Liang J; She Y; Zhu J; Wei L; Zhang L; Gao L; Wang Y; Xing J; Guo Y; Meng X; Li P
Int J Oncol; 2016 Nov; 49(5):2088-2104. PubMed ID: 27826616
[TBL] [Abstract] [Full Text] [Related]
8. Differentiation of normal and cancerous lung tissues by multiphoton imaging.
Wang CC; Li FC; Wu RJ; Hovhannisyan VA; Lin WC; Lin SJ; So PT; Dong CY
J Biomed Opt; 2009; 14(4):044034. PubMed ID: 19725745
[TBL] [Abstract] [Full Text] [Related]
